Speaking Faculty

Rick Doblin, Ph.D.Founder & Executive Director
Multidisciplinary Association of Psychedelic Studies (MAPS)

Charles Nichols, Ph.D.Prof., Dept. of Pharmacology & Experimental Therapeutics
LSU Health Sciences Center

Frederick Barrett, Ph.D.Assistant Professor of Psychiatry & Behavioral Sciences
Johns Hopkins School of Medicine

Bryan Roth, MD, Ph.D.Michael Hooker Distinguished Professor
U. of North Carolina School of Medicine

Javier Gonzalez Maeso, Ph.D.Professor of Physiology and Biophysics
VCU School of Medicine

Alan Kozikowski, Ph.D.Chief Scientific Officer
Bright Minds

Henri Sant-CassiaFounding Partner
The Conscious Fund

JR RahnCo-Founder,
Co-CEO
MindMed

Boris Heifets, MD, Ph.D.Assistant Professor, Dept. of Anesthesiology, Perioperative & Pain Medicine
Stanford University School of Medicine

Neiloufar Family, Ph.D.Psychiatric Research Director
Eleusis

Stephen Ross, MDAssociate Director
NYU Langone Health Center for Psychedelic Medicine

Shlomi RazChief Executive Officer
Eleusis

Jesper Langgaard Kristensen, Ph.D.Prof., Medicinal Chemistry, Dept. of Drug Design & Pharmacology/Chief Scientific Officer
University of Copenhagen/Lophora

Judy Ashworth, MDVice President, Rx Strategic Services and Chief Medical Officer
Pinney Associates

Marion Coe, Ph.D.Scientist
Pinney Associates

Timothy KoChief Executive Officer
Entheon Biomedical

Tristan McClure-Begley, Ph.D.Program Manager, Focused Pharma
Defense Advanced Research Projects Agency (DARPA)

Revati Shreeniwas, MDChief Medical Officer
Bright Minds

Jack Henningfield, Ph.D.VP, Research, Health Policy, & Abuse Liability
Pinney Associates